RxDoctor Payments Data

Adrian Colon Laracuente

Obstetrics · San Juan, PRNPI 1174629034

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 20 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 11 manufacturers reported payments, led by Merck at 27.5% of the total. Reporting peaked in 2019 at $603 and has fallen 80.3% since, to $119 in 2025.

$1,555in general payments, 2019–2025

Across 20 payments — averaging $77.73 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Merck$428
  • AbbVie$220
  • BD$152
  • Hologic Sales And Service, LLC$149
  • Organon$125
  • Johnson And Johnson International$117
  • plus $364 from 5 others

What the payments were for

  • Food & beverage$1,555100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Merck6$428
AbbVie2$220
BD2$152
Hologic Sales And Service, LLC1$149
Organon1$125
Johnson And Johnson International1$117
Medtronic1$100
Roche Diagnostics Corporation1$92
Smith+Nephew1$87
PBG Puerto Rico LLC3$61
E.r. Squibb & Sons, L.L.C.1$25

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,555 in reported general payments places this provider in the 80th percentile of 22 obstetrics providers in Puerto Rico.

See all obstetrics providers in Puerto Rico

Medicare billing

Part B allowed, 2024
$11,067
Medicare patients
19
Services billed
40

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Estradiol114$7,959
SynthroidLevothyroxine Sodium11$1,092
Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip29$791
Metronidazole15$762
Rosuvastatin Calcium15$323
Fluconazole27$255
Medroxyprogesterone Acetate12$115
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim11$41

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieSynthroid$220$1,09211 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 22 obstetrics providers in Puerto Rico.

Other obstetrics in San Juan

See the full list for Puerto Rico

Where these figures come from

Is this you, or does something look wrong? →